Drug Type siRNA |
Synonyms CCT 417, CCT417 |
Target |
Action antagonists |
Mechanism CB1 antagonists(Cannabinoid CB1 receptor antagonists), LEPR antagonists(Leptin receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Leptin Receptor Deficiency | Preclinical | Canada | 01 Feb 2025 |





